| Sporomusa subbranch| Sporomusaceae| Sporomusaceae Campbell et al. 2015
Actinomycetales Characteristics: Actinomycetales is an order of bacteria that includes various families, and members of this order are characterized by their filamentous growth and the formation of spore-like structures. Some actinomycetes have important roles in soil ecology.
Antibiotic Production: Some bacteria within the Actinomycetales order, but not necessarily within the family Sporomusaceae specifically, are well-known for their ability to produce antibiotics. These antibiotics have been used in medicine for their antimicrobial properties.
Environmental Roles: Actinomycetes, including those in the family Sporomusaceae, contribute to the decomposition of organic matter in soil. They play important roles in nutrient cycling in various ecosystems.
Limited Information on Health Impacts: Detailed information about the health impacts of Sporomusaceae, especially in the context of human health, is limited. Actinomycetes are generally considered environmental bacteria and are not commonly associated with human infections.
Potential for Biotechnological Applications: Actinomycetes, including those in the Sporomusaceae family, have been studied for their biotechnological potential. Some produce enzymes and bioactive compounds that have applications in industry and medicine.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Labs | 0.93 | 6 | 334 | 0 | 300 | 109.4 | 81 | 97.3 | 0 | 173 | 0 %ile | 100 %ile | ||
biomesight | 64.38 | 0 | 50 | 10 | 120 | 0 | 318 | 83 | 50 | 119.7 | 10 | 150 | 2.8 %ile | 90.9 %ile |
thorne | 100 | 6 | 83 | 0 | 58 | 24.2 | 19 | 17 | 9 | 39 | 0 %ile | 100 %ile | ||
thryve | 68.23 | 0 | 62 | 17 | 168 | 0 | 2129 | 228.4 | 52 | 969.6 | 3 | 199 | 7.5 %ile | 90.1 %ile |
ubiome | 4.31 | 22 | 16999 | 0 | 7565 | 1298 | 230 | 3197.5 | 9 | 785 | 0 %ile | 100 %ile |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|---|---|---|---|
Thorne (20/80%ile) | 9.17 | 19.97 | 0.0009 | 0.002 |
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
BiomeSight | 68.471 % | 0.008 % | 0.012 % | 1961.0 | 2864 |
BiomeSightRdp | 12.5 % | 0.005 % | 0.002 % | 4.0 | 32 |
bugspeak | 100 % | 0.016 % | % | 1.0 | 1 |
CerbaLab | 66.667 % | 0.008 % | 0.002 % | 2.0 | 3 |
custom | 5.085 % | 0.002 % | 0.001 % | 3.0 | 59 |
es-xenogene | 13.793 % | 0.021 % | 0.011 % | 4.0 | 29 |
Medivere | 100 % | 0.013 % | 0.011 % | 7.0 | 7 |
Thorne | 82.222 % | 0.002 % | 0.002 % | 74.0 | 90 |
Thryve | 70.427 % | 0.024 % | 0.109 % | 974.0 | 1383 |
uBiome | 4.293 % | 0.13 % | 0.32 % | 34.0 | 792 |
Click on Impact for information if high or low levels are causing the impact
Magnitude | Impact | Symptom |
---|
|
And display level must be raised above public.
Data comes from FoodMicrobionet. For the meaning of weight, see that site. The bacteria does not need to be alive to have an effect.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.